<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04680039</url>
  </required_header>
  <id_info>
    <org_study_id>PPGESKD001</org_study_id>
    <nct_id>NCT04680039</nct_id>
  </id_info>
  <brief_title>Early Warning of Intradialytic Hypotension in Hemodialysis Patients</brief_title>
  <official_title>Noninvasive Hemodynamic Parameters Measurements as a Tool for Early Warning of Intradialytic Hypotension in Hemodialysis Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Biobeat Technologies Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Biobeat Technologies Ltd.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study, the investigators will monitor patients undergoing hemodialysis treatment with&#xD;
      a non-invasive wearable PPG-based device. Measurements will include blood pressure, heart&#xD;
      rate, oxygen saturation, stroke volume, cardiac output, cardiac index and systemic vascular&#xD;
      resistance, among others. The aim is to diagnose intradialytic hypotension more rapidly than&#xD;
      with current noninvasive methods and prevent related poor outcomes.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 15, 2021</start_date>
  <completion_date type="Anticipated">October 2021</completion_date>
  <primary_completion_date type="Anticipated">August 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of participants with intradialytic hypotension</measure>
    <time_frame>Through study completion, an average of 1 year.</time_frame>
    <description>Using a PPG-based non-invasive wearable monitor to allow early detection of intradialytic hypotension</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Determining the pathogenesis of intradialytic hypotension</measure>
    <time_frame>Through study completion, an average of 1 year.</time_frame>
    <description>Continuous monitoring of numerous hemodynamic parameters will allow to determine the pathogenesis</description>
  </secondary_outcome>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Hypotension of Hemodialysis</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Continuous monitoring</intervention_name>
    <description>Identifying intradialytic hypotension using a PPG-based wearable monitor</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        150 adult subjects (â‰¥18 years) with end stage kidney disease (ESKD) undergoing chronic&#xD;
        hemodialysis (HD) treatments in Hadassah Ein-Kerem medical center. A patient can&#xD;
        participate more than once.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Patients with EKSD undergoing chronic hemodialysis treatments for &gt; 3 months.&#xD;
&#xD;
          2. Patients must be able to adhere to the visit schedule and protocol requirements and be&#xD;
             available to complete the study.&#xD;
&#xD;
          3. Patients must satisfy a medical examiner about their fitness to participate in the&#xD;
             study.&#xD;
&#xD;
          4. Patients must provide written informed consent to participate in the study.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Patients with an inability to communicate well with the Principal investigator (PI)&#xD;
             and staff (i.e., language problem, poor mental development, or impaired cerebral&#xD;
             function).&#xD;
&#xD;
          2. Withholding the dialysis session for any reason prior to initiation.&#xD;
&#xD;
          3. Minors under the age of 18.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>120 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dean Nachman, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Hadassah Ein Kerem Medical Center, Jerusalem, Israel</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Arik Eisenkraft, MD</last_name>
    <phone>+972529210896</phone>
    <email>dr.arik@bio-beat.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>The Hadassah Ein Kerem Medical Center</name>
      <address>
        <city>Jerusalem</city>
        <zip>91120</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dean Nachman, MD</last_name>
      <phone>+972-50-2217665</phone>
      <email>deannahman@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>December 14, 2020</study_first_submitted>
  <study_first_submitted_qc>December 20, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 22, 2020</study_first_posted>
  <last_update_submitted>May 23, 2021</last_update_submitted>
  <last_update_submitted_qc>May 23, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 25, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Hemodialysis</keyword>
  <keyword>Intradialytic hypotension</keyword>
  <keyword>Remote Monitoring</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypotension</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

